Sanjia Dean cast a case, dealers were interviewed... National crackdown on consumables rebates

Pharma Network January 27 - Central Commission for Discipline Inspection: two months and six times emphasis on medical anti-corruption January 25, the People's Daily, the 01st edition published the "Fifth Plenary Session of the 19th Central Commission for Discipline Inspection of the Communist Party of China Bulletin."
The Central Commission for Discipline Inspection stressed in its deployment of the 2021 task that corruption and style of work in the fields of education, medical care, food and drug safety should be continued, that the "umbrella" of black-related evils should be resolutely punished, and that the governance mechanism for harming the interests of the masses in the field of people's livelihood should be improved.
in less than two months since December, this is the sixth time the Central Commission for Discipline Inspection has emphasized medical anti-corruption.
December 10, the Central Commission for Discipline Inspection issued two articles on the purchase and sale of medicine corruption, looking through the medical corruption case file, we can find that the personnel involved in the Chinese medicine department staff occupy a larger proportion.
December 24, the official website of the Central Commission for Discipline Inspection issued a notice that, according to the Yunnan Provincial Commission for Discipline Inspection, the former vice president of the Yunnan Provincial Hospital for Cardiovascular Disease, Ma, suspected of serious disciplinary violations, has voluntarily committed a case, is currently under disciplinary review and supervision investigation.
January 17, the official website of the Central Commission for Discipline Inspection issued "new regulations restricting the behavior of pharmaceutical representatives to cut off the drug rebate interest chain" shows that the pharmaceutical industry ushered in more stringent supervision.
the problem of rebates is very harmful, but the blame should not be entirely attributed to the pharmaceutical representatives, sub-pharmaceutical companies in the operating concept of deviation is the deeper reason.
January 22nd, the Central Commission for Discipline Inspection continued to release details of the fall of former Shenzhen health system officials, referring to the bribery received from the access and enforcement regulatory process as head of the health supervision and administration department, so that some inferior medical institutions were exempted from regulatory penalties.
, on December 9 last year, Yiwu TCM Hospital conducted a group interview with more than 20 drug suppliers.
earlier, Beijing University of Traditional Chinese Medicine Fangshan Hospital Discipline Commission also organized a drug, medical supplies suppliers clean commitment collective interview, a total of more than 50 pharmaceutical, medical supplies suppliers were interviewed.
anti-corruption, not only in our country medical anti-corruption is not only our country needs to focus on solving the problem, in the United States, Germany and other countries is still a difficult problem, of which Germany is more typical.
In 1994, the Scandal of Rebates for the Sale of Heart Valves in Germany shocked German society, and by July 1997, the prosecution had initiated more than 1,500 investigations involving some 11,000 cases involving 32 university-affiliated hospitals throughout Germany.
since then, Germany has paid real attention to corruption in the health care sector, but today it remains a serious problem in German society.
Montgomery, president of the German Doctors Association, told the media earlier this year that in 2012 alone, there were nearly 1,000 investigations in Germany into doctors accepting bribes from pharmaceutical companies, 480 of which involved a pharmaceutical giant paying bribes to doctors so that doctors could prioritize the company's products when prescribing to patients, according to People's Daily Online.
the key to corruption in the medical industry is the interdependence between medical providers and a special and close interdependence between doctors and pharmaceutical product suppliers, according to a paper published in the journal Medicine and Philosophy by researchers at Jiangsu University School of Law.
On the one hand, the medical side relies on the funding of the pharmaceutical product supplier in many fields, on the other hand, the pharmaceutical product supplier also has a certain dependence on the medical side, so many medical corruption is very hidden, it is difficult to distinguish from the legitimate behavior.
Germany's judicial practice and academia have realized that people's creativity in medical business relations is endless, how to properly determine illegal "interests" has always been a difficult problem, and because of the need for medical business cooperation, the medical anti-corruption has been caught in a strange circle of contradictions: on the one hand, the judiciary must do its utmost to review all medical business contacts, any agreement or agreement can constitute medical corruption "preliminary suspicion";
the judiciary must, on the one hand, expand the interpretation of "interests" and, on the other hand, apply the law carefully to prevent excessive legal intervention from stifling legitimate scientific research and economic incentives.
the medical lawyer system work? Prior to this, the relevant researchers of China Pharmaceutical University have published an article that the public hospital drug market did not follow the general market to follow the "oversupply price rise, oversupply price decline", "the cheaper the price of things sold more" and other price equilibrium theory of the most basic economic principles.
, demand for medicines in China has risen as prices have risen.
Liu Pengcheng, a project researcher at the National Center for Drug Policy and Pharmaceutical Industry Economics at China Pharmaceutical University, has analyzed Seberan devices mainly because product users and selectors in the pharmaceutical industry are separated - consumers pay, but they can't decide which consumables or drugs to use.
the medical lawyer system be one of the solutions, in addition to cutting the chain of interests between physicians and products? Gu Xingrong, a second-level professor at guangzhou Business School, has analysed that under the existing hospital operation mechanism, it may be a feasible solution to ease the strained doctor-patient relationship and implement the medical lawyer system.
through the cultivation of medical lawyers, instead of patients to enhance the patient's product choice, that is, each medical service for patients need to be approved by a lawyer before it can be implemented, can effectively prevent medical corruption.
same time, in the event of a doctor-patient conflict, the patient may also entrust a medical lawyer to fight a lawsuit, or a medical lawyer may explain the situation to the patient and his relatives to alleviate the doctor-patient conflict.
the United States and Japan have already generally implemented the medical lawyer system, so that the equality between doctors and patients has improved, the relationship has improved.
other view, but in our country, the huge gap between the number of patients and the number of medical lawyers, as well as primary health care, patient education to be developed, and the feasibility of the medical lawyer system put a question mark.